The agenda of the AGM 2023 includes the recommendation of the Supervisory Board, endorsed by Philips' Chief Executive Officer to the shareholders to re-appoint
Additionally, it will be proposed to the shareholders to re-appoint
The agenda further includes the proposals to re-appoint EY as the company's external auditor for a term of one year starting
Finally, the agenda also includes a number of recurring items, such as the 2022 Remuneration Report as included in the Annual Report 2022, and the proposals to adopt the company's financial statements and dividend.
The AGM will be held at the
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in
Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips' organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
Contact:
Tel: +31 20 59 77055
(C) 2023 Electronic News Publishing, source